Pre-admission clinical course of meningococcal disease and opportunities for the earlier start of appropriate intervention: A prospective epidemiological study on 752 patients in the Netherlands, 2003-2005

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 27, Issue 10, 2008, Pages 985-992

  De Greeff, S C ^a   De Melker, H E ^a   Schouls, L M ^a   Spanjaard, L ^b   Van Deuren, M ^c  

^a NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

^c RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; MENINGOCOCCUS VACCINE;

ADOLESCENT; ADULT; ARTICLE; BLOOD GROUP TYPING; CHILD; CONTROLLED STUDY; DISEASE COURSE; FATALITY; HEALTH CARE DELIVERY; HUMAN; MAJOR CLINICAL STUDY; MENINGOCOCCOSIS; NEISSERIA MENINGITIDIS; NETHERLANDS; PRIORITY JOURNAL; SKIN DEFECT; SYMPTOMATOLOGY; VACCINATION;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; EPIDEMIOLOGIC STUDIES; FEMALE; HOSPITALIZATION; HUMANS; INFANT; INFANT, NEWBORN; MALE; MENINGITIS, MENINGOCOCCAL; MIDDLE AGED; NETHERLANDS; PROSPECTIVE STUDIES; RISK FACTORS; TIME FACTORS;

EID: 53549131506     PISSN: 09349723     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10096-008-0535-1     Document Type: Article

References (32)

1. M van Deuren P Brandtzaeg JW van der Meer 2000 Update on meningococcal disease with emphasis on pathogenesis and clinical management Clin Microbial Rev 13 144 166
2. P Brandtzaeg M van Deuren 2005 Meningococcal infections at the start of the 21st century Adv Pediatr 52 129 162
3. CL Trotter NJ Andrews EB Kaczmarski E Miller ME Ramsay 2004 Effectiveness of meningococcal serogroup C conjugate vaccine 4 years after introduction Lancet 364 365 367
4. SC de Greeff HE de Melker L Spanjaard LM Schouls A van Derende 2006 Protection from routine vaccination at the age of 14 months with meningococcal serogroup C conjugate vaccine in the Netherlands Pediatr Infect Dis J 25 79 80
5. A Larrauri R Cano M García S Mateo 2005 Impact and effectiveness of meningococcal C conjugate vaccine following its introduction in Spain Vaccine 23 4097 4100
6. JD Mooney P Christie C Robertson SC Clarke 2004 The impact of meningococcal serogroup C conjugate vaccine in Scotland Clin Infect Dis 39 349 356
7. A Halstensen SH Pedersen B Haneberg B Bjorvatn CO Solberg 1987 Case fatality of meningococcal disease in western Norway Scand J Infect Dis 19 35 42
8. I Smith DA Caugant EA Høiby T Wentzel-Larsen A Halstensen 2006 High case-fatality rates of meningococcal disease in Western Norway caused by serogroup C strains belonging to both sequence type (ST)-32 and ST-11 complexes, 1985-2002 Epidemiol Infect 134 1195 1202
9. AL Wood SJ O'Brien 1996 How long is too long? Determining the early management of meningococcal disease in Birmingham Public Health 110 237 239
10. C Trotter S Samuelsson A Perrocheau S de Greeff H de Melker S Heuberger M Ramsay 2005 Ascertainment of meningococcal disease in Europe Euro Surveill 10 247 250
11. SC de Greeff L Spanjaard J Dankert CJ Hoebe N Nagelkerke HE de Melker 2006 Underreporting of meningococcal disease incidence in the Netherlands: results from a capture-recapture analysis based on three registration sources with correction for false positive diagnoses Eur J Epidemiol 21 315 321
12. Rothman KJ (2002) Epidemiology: an introduction. Oxford University Press, New York
13. Netherlands Reference Laboratory for Bacterial Meningitis (AMC/RIVM) (2006) Bacterial meningitis in the Netherlands; annual report 2005. University of Amsterdam, Amsterdam
14. M Ramsay E Kaczmarski M Rush R Mallard P Farrington J White 1997 Changing patterns of case ascertainment and trends in meningococcal disease in England and Wales Commun Dis Rev 7 R49 R54
15. G Paret N Keller A Barzilai M Zemach D Guttman A Vardi G Shatzberg H Cohen Z Barzilay 1999 Invasive meningococcal disease: patient and strain characteristics set new challenge for prevention and control Infection 27 261 264
16. M Shigematsu KL Davison A Charlett NS Crowcroft 2002 National enhanced surveillance of meningococcal disease in England, Wales and Northern Ireland, January 1999-June 2001 Epidemiol Infect 129 459 470
17. I Smith AT Bjørnevik IM Augland A Berstad T Wentzel-Larsen A Halstensen 2006 Variations in case fatality and fatality risk factors of meningococcal disease in Western Norway, 1985-2002 Epidemiol Infect 134 103 110
18. K Bøvre LO Frøholm P Gaustad E Holten EA Høiby 1983 Some agent characteristics and their coexistence related to occurrence and severity of systemic meningococcal disease in Norway, Winter 1981-1982 NIPH Ann 6 75 84
19. A Waage A Halstensen T Espevik 1987 Association between tumour necrosis factor in serum and fatal outcome in patients with meningococcal disease Lancet 1 355 357
20. P Brandtzaeg P Kierulf P Gaustad A Skulberg JN Bruun S Halvorsen E Sørensen 1989 Plasma endotoxin as a predictor of multiple organ failure and death in systemic meningococcal disease J Infect Dis 159 195 204
21. M van Deuren C Neeleman LG Van't Hek JW van der Meer 1998 A normal platelet count at admission in acute meningococcal disease does not exclude a fulminant course Intensive Care Med 24 157 161
22. ER Stiehm DS Damrosch 1966 Factors in the prognosis of meningococcal infection. Review of 63 cases with emphasis on recognition and management of the severely ill patient J Pediatr 68 457 467
23. JF Sinclair CH Skeoch D Hallworth 1987 Prognosis of meningococcal septicaemia Lancet 2 38
24. FA Riordan O Marzouk AP Thomson JA Sills CA Hart 2002 Prospective validation of the Glasgow Meningococcal Septicaemia Prognostic Score. Comparison with other scoring methods Eur J Pediatr 161 531 537
25. MJ Thompson N Ninis R Perera R Mayon-White C Phillips L Bailey A Harnden D Mant M Levin 2006 Clinical recognition of meningococcal disease in children and adolescents Lancet 367 397 403
26. T Tønjum F Nilsson JN Bruun B Haneberg 1983 The early phase of meningococcal disease NIPH Ann 6 175 181
27. DB Louria P Sen R Kapila E Johnson L Smith R Roberts 1985 Anterior thigh pain or tenderness. A diagnostically useful manifestation of bacteremia Arch Intern Med 145 657 658
28. SH Inkelis D O'Leary VJ Wang R Malley MK Nicholson N Kuppermann 2002 Extremity pain and refusal to walk in children with invasive meningococcal disease Pediatrics 110 e3
29. S Granier P Owen R Pill L Jacobson 1998 Recognising meningococcal disease in primary care: qualitative study of how general practitioners process clinical and contextual information BMJ 316 276 279
30. Health Protection Agency (2008) Meningococcal disease. Available online at: http://www.hpa.org.uk/infections/topics_az/meningo/guidelines.htm
31. SJ Hackett M Guiver J Marsh JA Sills AP Thomson EB Kaczmarski CA Hart 2002 Meningococcal bacterial DNA load at presentation correlates with disease severity Arch Dis Child 86 44 46
32. R Øvstebø P Brandtzaeg B Brusletto KB Haug K Lande EA Høiby P Kierulf 2004 Use of robotized DNA isolation and real-time PCR to quantify and identify close correlation between levels of Neisseria meningitidis DNA and lipopolysaccharides in plasma and cerebrospinal fluid from patients with systemic meningococcal disease J Clin Microbiol 42 2980 2987